This HTML5 document contains 40 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/pdb/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/kegg-compound/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/pubchem-substance/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/drugbank/
n16http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n15http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/drug/DB02536/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02536
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n15:DB02536 n16:DB02536
dcterms:title
(2r)-2,3-Dihydroxypropanal
adms:identifier
n6:79014 n7:46508159 n8:5445 n9:C02154 n10:3GR n11:731 n12:DB02536
n3:IUPAC-Name
n4:271B4053-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4059-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4058-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4055-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4056-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4057-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4051-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B404F-363D-11E5-9242-09173F13E4C5 n4:271B4052-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4050-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B405F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4060-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B405A-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B405B-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B405D-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B405C-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B405E-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
367-47-5
n3:Bioavailability
n4:271B4065-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4067-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4068-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B4069-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4064-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4063-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4066-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4054-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4061-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4062-363D-11E5-9242-09173F13E4C5